Hyaluronan regulates transforming growth factor-β1 receptor compartmentalization

被引:114
作者
Ito, T [1 ]
Williams, JD [1 ]
Fraser, DJ [1 ]
Phillips, AO [1 ]
机构
[1] Cardiff Univ, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales
关键词
D O I
10.1074/jbc.M403135200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor-beta1 (TGF-beta1) is a key cytokine involved in the pathogenesis of fibrosis in many organs. We previously demonstrated in renal proximal tubular cells that the engagement of the extracellular polysaccharide hyaluronan with its receptor CD44 attenuated TGF-beta1 signaling. In the current study we examined the potential mechanism by which the interaction between hyaluronan ( HA) and CD44 regulates TGF-beta receptor function. Affinity labeling of TGF-beta receptors demonstrated that in the unstimulated cells the majority of the receptor partitioned into EEA-1-associated non-lipid raft-associated membrane pools. In the presence of exogenous HA, the majority of the receptors partitioned into caveolin-1 lipid raft-associated pools. TGF-beta1 increased the association of activated/phosphorylated Smad proteins with EEA-1, consistent with activation of TGF-beta1 signaling following endosomal internalization. Following addition of HA, caveolin-1 associated with the inhibitory Smad protein Smad7, consistent with the raft pools mediating receptor turnover, which was facilitated by HA. Antagonism of TGF-beta1-dependent Smad signaling and the effect of HA on TGF-beta receptor associations were inhibited by depletion of membrane cholesterol using nystatin and augmented by inhibition of endocytosis. The effect of HA on TGF-beta receptor trafficking was inhibited by inhibition of HA-CD44 interactions, using blocking antibody to CD44 or inhibition of MAP kinase activation. In conclusion, we have proposed a model by which HA engagement of CD44 leads to MAP kinase-dependent increased trafficking of TGF-beta receptors to lipid raft-associated pools, which facilitates increased receptor turnover and attenuation of TGF-beta1-dependent alteration in proximal tubular cell function.
引用
收藏
页码:25326 / 25332
页数:7
相关论文
共 54 条
  • [1] Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis
    Akagi, Y
    Isaka, Y
    Arai, M
    Kaneko, T
    Takenaka, M
    Moriyama, T
    Kaneda, Y
    Ando, A
    Orita, Y
    Kamada, T
    Ueda, N
    Imai, E
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (01) : 148 - 155
  • [2] BASSOLS A, 1988, J BIOL CHEM, V263, P3039
  • [3] SIGNIFICANCE OF TUBULOINTERSTITIAL CHANGES IN THE RENAL CORTEX FOR THE EXCRETORY FUNCTION AND CONCENTRATION ABILITY OF THE KIDNEY - A MORPHOMETRIC CONTRIBUTION
    BOHLE, A
    MACKENSENHAEN, S
    VONGISE, H
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1987, 7 (06) : 421 - 433
  • [4] TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR
    BORDER, WA
    RUOSLAHTI, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) : 1 - 7
  • [5] TRANSFORMING GROWTH FACTOR-B REGULATES PRODUCTION OF PROTEOGLYCANS BY MESANGIAL CELLS
    BORDER, WA
    OKUDA, S
    LANGUINO, LR
    RUOSLAHTI, E
    [J]. KIDNEY INTERNATIONAL, 1990, 37 (02) : 689 - 695
  • [6] SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1
    BORDER, WA
    OKUDA, S
    LANGUINO, LR
    SPORN, MB
    RUOSLAHTI, E
    [J]. NATURE, 1990, 346 (6282) : 371 - 374
  • [7] NATURAL INHIBITOR OF TRANSFORMING GROWTH-FACTOR-BETA PROTECTS AGAINST SCARRING IN EXPERIMENTAL KIDNEY-DISEASE
    BORDER, WA
    NOBLE, NA
    YAMAMOTO, T
    HARPER, JR
    YAMAGUCHI, Y
    PIERSCHBACHER, MD
    RUOSLAHTI, E
    [J]. NATURE, 1992, 360 (6402) : 361 - 364
  • [8] BORDER WA, 1994, NEW ENGL J MED, V331, P1286
  • [9] ANTAGONISTS OF TRANSFORMING GROWTH-FACTOR-BETA - A NOVEL-APPROACH TO TREATMENT OF GLOMERULONEPHRITIS AND PREVENTION OF GLOMERULOSCLEROSIS
    BORDER, WA
    NOBLE, NA
    YAMAMOTO, T
    TOMOOKA, S
    KAGAMI, S
    [J]. KIDNEY INTERNATIONAL, 1992, 41 (03) : 566 - 570
  • [10] TGF-beta in kidney fibrosis: A target for gene therapy
    Border, WA
    Noble, NA
    [J]. KIDNEY INTERNATIONAL, 1997, 51 (05) : 1388 - 1396